MTHFR gene polymorphism and risk of myeloid leukemia: a meta-analysis

Tumor Biology

Volumn 35, Issue 9, 2014, Pages 8913-8919

  Dong, Song ^a   Liu, Yueling ^a   Chen, Jieping ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

MTHFR; Myeloid leukemia; SNP

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

ADULT; ARTICLE; CHILD; DOMINANT GENE; ETHNICITY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC SUSCEPTIBILITY; GENOTYPE; HETEROZYGOSITY; HETEROZYGOTE DETECTION; HIGH RISK POPULATION; HUMAN; MYELOID LEUKEMIA; RECESSIVE GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW; ASIAN CONTINENTAL ANCESTRY GROUP; CAUCASIAN; ETHNOLOGY; GENE LINKAGE DISEQUILIBRIUM; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; RISK FACTOR;

ASIAN CONTINENTAL ANCESTRY GROUP; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LEUKEMIA, MYELOID; LINKAGE DISEQUILIBRIUM; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84919838613     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1007/s13277-014-2082-y     Document Type: Article

References (33)

1. Bloomfield CD, Caligiury M. Molecular biology of leukemias. In: DeVita VT, Hellman S, Rosenberg SA, editors. Cancer: principles and practice of oncology. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 2389–404.
2. Rowley JD. The critical role of chromosome translocations in human leukemias. Annu Rev Genet. 1998;32:495–519.
3. Pui CH. Childhood leukaemias. 2nd ed. Cambridge: Cambridge University Press; 2006.
4. Gabert J et al. Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia—a Europe Against Cancer program. Leukemia. 2003;17(12):2318–57.
5. Smith MT, Zhang L. Biomarkers of leukemia risk: benzene as a model. Environ Health Perspect. 1998;106 Suppl 4:937–46.
6. Robien K, Ulrich CM. 5,10-Methylenetetrahydrofolate reductase polymorphisms and leukemia risk: a HuGE minireview. Am J Epidemiol. 2003;157(7):571–82.
7. Blount BC et al. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci U S A. 1997;94(7):3290–5.
8. Duthie SJ et al. Impact of folate deficiency on DNA stability. J Nutr. 2002;132(8 Suppl):2444S–9S.
9. Franco RF et al. A second mutation in the methylenetetrahydrofolate reductase gene and the risk of venous thrombotic disease. Br J Haematol. 1999;105(2):556–9.
10. Goyette P et al. Human methylenetetrahydrofolate reductase: isolation of cDNA mapping and mutation identification. Nat Genet. 1994;7(4):551.
11. Frosst P et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10(1):111–3.
12. Weisberg I et al. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab. 1998;64(3):169–72.
13. Skibola CF et al. Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. Proc Natl Acad Sci U S A. 1999;96(22):12810–5.
14. da Costa Ramos FJ et al. Association between the MTHFR A1298C polymorphism and increased risk of acute myeloid leukemia in Brazilian children. Leuk Lymphoma. 2006;47(10):2070–5.
15. Hur M et al. Methylenetetrahydrofolate reductase A1298C genotypes are associated with the risks of acute lymphoblastic leukaemia and chronic myelogenous leukaemia in the Korean population. Clin Lab Haematol. 2006;28(3):154–9.
16. Moon HW et al. MTHFR 677CC/1298CC genotypes are highly associated with chronic myelogenous leukemia: a case–control study in Korea. Leuk Res. 2007;31(9):1213–7.
17. Higgins JP et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–60.
18. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–88.
19. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22(4):719–48.
20. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088–101.
21. Egger M et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–34.
22. Lightfoot TJ et al. Genetic variation in the folate metabolic pathway and risk of childhood leukemia. Blood. 2010;115(19):3923–9.
23. Lordelo GS et al. Association between methylenetetrahydrofolate reductase and glutathione S-transferase M1 gene polymorphisms and chronic myeloid leukemia in a Brazilian population. Genet Mol Res. 2012;11(2):1013–26.
24. Zheng MM et al. Association of single nucleotide polymorphism of methylenetetrahydrofolate reductase gene with susceptibility to acute leukemia. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2013;30(4):451–5.
25. Khorshied MM et al. Methylene tetrahydrofolate reductase (MTHFR) gene polymorphisms in chronic myeloid leukemia: an Egyptian study. Med Oncol. 2014;31(1):794.
26. Zintzaras E, Lau J. Trends in meta-analysis of genetic association studies. J Hum Genet. 2008;53(1):1–9.
27. Cheson BD. The chronic lymphocytic leukemias. In: DeVita VT, Hellman S, Rosenberg SA, editors. Cancer: principles and practice of oncology. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 2447–65.
28. Kantarjian HM, Faderl S, Talpaz M. Chronic myelogenous leukemia. In: DeVita VT, Hellman S, Rosenberg SA, editors. Cancer: principles and practice of oncology. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 2433–47.
29. Weinstein HJ, Tarbell N. Leukemias and lymphomas of childhood. In: DeVita VT, Hellman S, Rosenberg SA, editors. Cancer: principles and practice of oncology. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 2235–56.
30. van der Put NM et al. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet. 1998;62(5):1044–51.
31. Wang H et al. Methylenetetrahydrofolate reductase polymorphism C677T is a protective factor for pediatric acute lymphoblastic leukemia in the Chinese population: a meta-analysis. Genet Test Mol Biomark. 2012;16(12):1401–7.
32. Yan J et al. A meta-analysis of MTHFR C677T and A1298C polymorphisms and risk of acute lymphoblastic leukemia in children. Pediatr Blood Cancer. 2012;58(4):513–8.
33. Cole P, Rodu B. Descriptive epidemiology: cancer statistics. In: DeVita VT, Hellman S, Rosenberg SA, editors. Cancer: principles and practice of oncology. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 228–41.